Molgramostim improves exercise distance and duration in autoimmune pulmonary alveolar proteinosis: exploratory IMPALA-2 trial data.
- DOI
- 10.1093/annalsats/aaoag301
- Published
- 2026 Sep 22
- Container
- Annals of the American Thoracic Society
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1093/annalsats/aaoag301,
title = {Molgramostim improves exercise distance and duration in autoimmune pulmonary alveolar proteinosis: exploratory IMPALA-2 trial data.},
author = {McCarthy C and Bonella F and Inoue Y and Trapnell BC and Wang T and Ataya A and Arena R and Robinson B and Fleming R and Pratt R and Wasfi Y},
year = {2026},
journal = {Annals of the American Thoracic Society},
doi = {10.1093/annalsats/aaoag301},
url = {https://doi.org/10.1093/annalsats/aaoag301}
}RIS
TY - JOUR TI - Molgramostim improves exercise distance and duration in autoimmune pulmonary alveolar proteinosis: exploratory IMPALA-2 trial data. AU - McCarthy C AU - Bonella F AU - Inoue Y AU - Trapnell BC AU - Wang T AU - Ataya A AU - Arena R AU - Robinson B AU - Fleming R AU - Pratt R AU - Wasfi Y PY - 2026 JO - Annals of the American Thoracic Society DO - 10.1093/annalsats/aaoag301 UR - https://doi.org/10.1093/annalsats/aaoag301 ER -
APA
C, M., F, B., Y, I., BC, T., T, W., A, A., R, A., B, R., R, F., R, P., & Y, W. (2026). Molgramostim improves exercise distance and duration in autoimmune pulmonary alveolar proteinosis: exploratory IMPALA-2 trial data.. Annals of the American Thoracic Society. https://doi.org/10.1093/annalsats/aaoag301
Source records
- pubmed · retrieved 2026-09-25T13:16:09.324Z
- europe-pmc · retrieved 2026-09-25T13:16:09.335Z